GLP-1
TopicOn 5 shows in Health & Science this week · 1.2× usual · most on The Peter Attia Drive
GLP-1 (glucagon-like peptide-1) is a naturally occurring peptide hormone produced mainly by intestinal enteroendocrine L-cells after food consumption, with additional production by certain brainstem neurons. It helps regulate blood glucose by stimulating glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and promoting satiety; the term is also commonly used in public discussion for GLP-1 receptor agonist medicines such as semaglutide and tirzepatide.
Rank this week
Share of the conversation
0.4‰ of what listeners heard
Reach this week
Tone this week
- Negative 2
- Neutral 2
Share of the conversation
Mentions of GLP-1 per 1,000 mentions of anything, 7-day rolling, health & science.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 10 | 0.47‰ | 1 |
| Sep 12 | 1.02‰ | 2 |
| Sep 14 | 1.15‰ | 1 |
| Sep 15 | 1.61‰ | 2 |
| Sep 21 | 2.34‰ | 6 |
| Sep 23 | 2.50‰ | 3 |
| Sep 26 | 2.64‰ | 2 |
| Sep 29 | 1.32‰ | 1 |
| Oct 3 | 0.45‰ | 1 |
| Oct 8 | 0.45‰ | 1 |
| Oct 9 | 0.84‰ | 2 |
| Oct 12 | 1.13‰ | 2 |
| Oct 13 | 1.59‰ | 2 |
| Oct 16 | 1.83‰ | 4 |
| Oct 19 | 1.61‰ | 1 |
| Oct 20 | 1.53‰ | 2 |
| Oct 21 | 1.67‰ | 1 |
| Oct 27 | 0.45‰ | 1 |
| Oct 29 | 0.52‰ | 1 |
| Nov 2 | 0.77‰ | 1 |
| Nov 3 | 1.01‰ | 2 |
| Nov 5 | 1.08‰ | 1 |
| Nov 7 | 1.58‰ | 2 |
| Nov 9 | 1.41‰ | 1 |
| Nov 11 | 0.99‰ | 1 |
| Nov 12 | 1.09‰ | 2 |
| Nov 13 | 1.45‰ | 2 |
| Nov 16 | 1.59‰ | 4 |
| Nov 20 | 0.89‰ | 1 |
| Nov 21 | 1.21‰ | 2 |
Why is it trending?· Last 7 days
GLP-1 debate spans benefits, costs, alternatives, and unanswered risks
On StarTalk with Neil deGrasse Tyson, Morgan McSweeney said GLP-1 drugs act through a natural body pathway and may eventually reduce brain-disease risk by improving cardiometabolic factors, though evidence will take years.[1][2]
On The Dr. Gabrielle Lyon Show, Dariush Mozaffarian called GLP-1s potentially effective but emphasized their high cost while discussing how increased use could affect overall food consumption.[3]
On The Dr. Josh Axe Show, Josh Axe and Shivani Gupta agreed GLP-1s may be appropriate when needed but questioned using them for inflammation when turmeric, ginger, and diet were presented as alternatives.[4]
On unPAUSED with Dr. Mary Claire Haver, Rachel Rubin said a survey of GLP-1 users and conference presentations are examining possible effects on sexual function, while noting that a paper’s hypothesis may lack data.[5]
On The Peter Attia Drive, Siddhartha Mukherjee described GLP-1s as tools for obesity and potentially inflammation, framing their role as a trial worth watching rather than a settled conclusion.[6]
Sources · 6 moments
- 1.StarTalk with Neil deGrasse Tyson · The Science of Lookmaxxing with Dr. NocChuck Nice · Oct 16 · Listen at 9:18 ↗
“So GLP-1, semaglutide, am I pronouncing that? Is that a naturally occurring peptide within the body?”
- 2.StarTalk with Neil deGrasse Tyson · The Science of Lookmaxxing with Dr. NocMorgan McSweeney · Oct 16 · Listen at 44:27 ↗
“It's going to take a long time for the data to give an answer either way. I would be surprised if the GLP -1 drugs, in improving all those cardiometabolic risk factors, didn't give some reduction in risk for brain disease in the future. It'”
- 3.The Dr. Gabrielle Lyon Show · Dr. Dariush Mozaffarian: How the Food System Got Us Sick. Can We Fix It?Dr. Gabrielle Lyon · Oct 20 · Listen at 1:18:22 ↗
“And if you say we should follow the money, which I agree, where is the money? Now we have increased use of GLP-1s, which obviously we're still really struggling with obesity. Do you think that that is going to affect overall consumption in”
- 4.The Dr. Josh Axe Show · The Spice That Fights Inflammation Better Than Ibuprofen | Dr Shivani GuptaJosh Axe · Oct 15 · Listen at 41:37 ↗
“You know, I've continued to see conventional medicine just continue to just prescribe more drugs. Right. And I just think it's making everybody worse. The most the fastest growing over the past two years have been these GLP ones.”
Written by AI from the cited moments; every quote is checked against the transcript.
Who is saying what about GLP-1
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Scott Kanoski4 claims on 1 show
“GLP-1 is a big player in that process. Not exclusively through the vagus nerve, but probably largely through the vagus nerve, through this paracrine mode of action.”
Huberman Lab · Oct 12 ↗ - Mary Ross Gilbert2 claims on 1 show
“definitely they have been some headwinds”
Bloomberg Intelligence · Aug 26 ↗ - Emily Cohn2 claims on 1 show
“this is going to be a huge potential tailwind for the retailers”
Bloomberg Intelligence · Sep 10 ↗
11 more with Pro.
Discussed alongside
Names that come up in the same conversations as GLP-1.
Embed this
Paste this on your site to show GLP-1's current trend:
<iframe src="https://podlume.ai/embed/e/glp-1" width="360" height="220" style="border:0" loading="lazy" title="GLP-1 on PodLume Trends"></iframe>